Dr. William David Boothe Jr., MD

Dr. Boothe practices at Associated Dermatologists in Tucson, Arizona.

Dr. Boothe's NPI, 1649711904, was assigned on March 19, 2017. Dr. Boothe graduated from Texas Tech University Health Sciences Center School of Medicine in 2017. Dr. Boothe's Texas license number on file is R9043.

Dr. Boothe's primary practice is Associated Dermatologists, at 6296 E Grant Rd, Tucson, AZ 85712 in Pima County. The practice phone is (520) 290-8555.

Dr. Boothe's primary practice is Associated Dermatologists in Tucson, Arizona. Dr. Boothe is also affiliated with Covenant Medical Center. The medical group on file is Lubbock Dermatology and Skin Cancer Center. Dmand AI also links Dr. Boothe to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Boothe practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Boothe's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Boothe is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Boothe's licenses on file in 3 states: Texas, Arizona and Montana.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, corns and calluses, facial skin infection and hives among the conditions Dr. Boothe treats.

CMS data shows 4,498 Medicare services from Dr. Boothe across 22 procedure codes in 2024, for 1,173 Medicare patients. Medicare paid $181,902 for them. Every service was in an office.

CMS counts 1,173 Medicare patients who saw Dr. Boothe in 2024. The largest group is 65 to 74, with 516 patients. 75% of them have high cholesterol, and 65% have high blood pressure. Their average risk score is 0.96, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Boothe's median patient age at 74, with 44% women.

In 2024, Dr. Boothe wrote 1,197 Medicare Part D claims for 605 patients. 97% of them were for generic drugs. CMS names the drug for 1,083 of them, across 21 drugs with 11 or more claims each, at $99,420 in total drug cost. In 2023, CMS named 1,071 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Boothe for performance year 2024, reported individually. Dr. Boothe accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 599 procedures of removal of skin lesions by Dr. Boothe, more than 88% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Boothe, published from 2019 to 2021. 2019 was the busiest year, with 2. The most frequent topics are Carcinoma, Squamous Cell and Skin Neoplasms. Dr. Boothe has published most often in Proc (Bayl Univ Med Cent). Dr. Boothe's most frequent co-authors are Cloyce L. Stetson, MD, Adewole S. Adamson, MD and Kelly A. Bennett, MD.

CMS Open Payments shows 120 general payments to Dr. Boothe from 21 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Amgen Inc. paid the most, $1,077.

Dr. Boothe graduated from Texas Tech University Health Sciences Center School of Medicine in 2017.

Dr. Boothe is in network with 17 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Cigna. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.